An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for IMMUNOGEN Inc
| Ticker | IMGN |
| FIGI | BBG000C2JTB5 |
| CUSIP | 45253H101 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 1 / 0.0% |
| Number of Shares | 1 |
About
ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts.An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the company's potent cell-killing agents attached as a "payload". The antibody serves to deliver the cell-killing agent specifically to cancer cells bearing its target and the payload serves to kill these cells. Wikipedia
Number of Shares
Top Institutional Holders for IMMUNOGEN Inc
| Holder | Number of Shares |
|---|---|
| HUNTINGTON NATIONAL BANK | 1 |